Multiple cardiovascular risk factor control: still a challenge?

Yusuf S Hawken S Ôunpuu S , et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study. J Cardiopulm Rehabil 2005; 25: 56–57.

Petrie JR Guzik TJ Touyz RM . Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Can J Cardiol 2018; 34: 575–584.

Chan M Bloomberg MR . Political Will Need to Win Fight against Noncommunicable Diseases, Geneva, Switzerland: World Health Organization, 2016.

Piepoli M Hoes AW Agewall S , et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2016; 37: 2315–2381.

Arnett DK, Blumenthal RS and Albert MA. 2019 ACC/AHA Guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2019; 140: e596–e646.

Smith SC Benjamin EJ Bonow RO . AHA/ACCF Secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update. Circulation 2011; 124: 2458–2473.

Kotseva K De Backer G De Bacquer D , et al. Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry. Eur J Prev Cardiol 2019; 26: 824–835.

Danchin N Almahmeed W Al-Rasadi K , et al. Achievement of low-density lipoprotein cholesterol goals in 18 countries outside Western Europe: the International ChoLesterol management Practice Study (ICLPS). Eur J Prev Cardiol 2018; 25: 1087–1094.

Bloom DJ, Santos RD and Daclin V. The challenge of multiple cardiovascular risk factor control outside western Europe: findings from the International ChoLesterol management Practice Study. Eur J Prev Cardiol. 2020; 27: 1403–1411.

Iestra JA Kromhout D van der Schouw YT , et al. Effect size estimates of lifestyle and dietary changes on all-cause mortality in coronary artery disease patients: a systematic review. Circulation 2005; 112: 924–934.

Chow CK Jolly S Rao-Melacini P , et al. Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes. Circulation 2010; 121: 750–758.

Piepoli M Corra U Dendale P . Challenges in secondary prevention after acute myocardial infarction: a call for action. Eur J Prev 2016; 23: 1994–2006.

Zullig LL Blalock DV Dougherty S . The new landscape of medication adherence improvement: where population health science meets precision medicine. Patient Pref Adher 2018; 12: 1225–1230.

Dawood N Vaccarino V Reid KJ , et al. Predictors of smoking cessation after a myocardial infarction: the role of institutional smoking cessation programs in improving success. Arch Intern Med 2008; 168: 1961–1967.

Lavie CJ Milani RV . Adverse psychological and coronary risk profiles in young patients with coronary artery disease and benefits of formal cardiac rehabilitation. Arch Intern Med 2006; 166: 1878–1883.

Giannuzzi P Temporelli PL Marchioli R , et al. Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network. Arch Intern Med 2008; 168: 2194–2204.

Zeng W Stason WB Fournier S , et al. Benefits and costs of intensive lifestyle modification programs for symptomatic coronary disease in Medicare beneficiaries. Am Heart J 2013; 165: 785–792.